Can we make science as fast as software? In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments.
Today
Martin Shkreli on AI, Pharma, and What Actually Matters
Erik Torenberg speaks with Martin Shkreli, American investor and businessman, about how he sees the AI landscape, from OpenAI to Anthropic, and what actually matters beyond the hype. They also talk through the future of computing, the limits of “vibe coding,” and why biotech and ... Show More
48m 47s
Apr 6
Peter Yang on Small Teams, Coding Agents, and Why Human Ambition Has No Ceiling
Anish Acharya speaks with Peter Yang, creator and product lead at Roblox, about how personal AI agents are replacing the apps we open every day, why coding agents feel like slot machines, and what happens when the cost of building software drops to near zero. They discuss why fut ... Show More
28m 37s
Yesterday
Balaji Srinivasan: Prove Correct, Not Just Go Direct
Erik Torenberg and Theo Jaffee speak with Balaji Srinivasan, angel investor, entrepreneur, and author of The Network State, about how AI is transforming media, eroding trust, and reshaping how information is created and verified. They discuss why systems like hiring, journalism, ... Show More
2h 1m
Feb 2025
Virtual Cell Models, Tahoe-100 and Data for AI-in-Bio with Vevo Therapeutics and the Arc Institute
On this week’s episode of No Priors, Sarah Guo is joined by leading members of the teams at Vevo Therapeutics and the Arc Institute – Nima Alidoust, CEO/Co-Founder at Vevo Therapeutics; Johnny Yu, CSO/Co-Founder at Vevo Therapeutics; Patrick Hsu, CEO/Co-Founder at Arc Institute; ... Show More
57m 40s
Nov 2025
How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ... Show More
48m 13s
Sep 2025
Value-Based Oncology at Scale: Inside Thyme Care
<p>Cancer care in the U.S. costs over $250 billion each year, and nearly 2 million Americans receive a new diagnosis annually, yet too often the journey begins with silence: no call, no plan, no guide.</p><p>In this episode, a16z’s Vineeta Agarwala and Jay Rughani talk with Thyme ... Show More
41m 16s
Apr 2021
Episode 1: Meet the Struggling Scientists
<p>In this first episode, you meet the Struggling Scientists Hosts, Suzanne and Jayron! We introduce ourselves and this Science Podcast and talk about our goals!</p><p>We are Jayron and Suzanne, 2 PhD students in the world of Medical Biochemistry. Welcome to our new Podcast The S ... Show More
9m 20s
Apr 2025
Biotech is about to change your world
The latest innovations in biotech are upending our approach to disease, longevity and climate change. Are we ready? This hour, TED speakers share ideas at the forefront of this new wave. Guests include co-founder of the Human Cell Atlas Aviv Regev, physical chemist Brad Ringeisen ... Show More
49m 37s
<p><strong>Natural First-Aid Healing: </strong><a href="https://" rel="noopener noreferrer" target="_blank">https://</a><a href="https://3rdrockessentials.com/" rel="noopener noreferrer" target="_blank">3rdrockessentials.com</a>, use code <strong>DAVE</strong>  ... Show More
